Anti-spike antibody response to the COVID vaccine in lymphoma patients

Anti-spike antibody response to the COVID vaccine in lymphoma patients

Show other versions (1)

Patients with hematologic malignancies have poor outcomes from COVID infection and are less likely to mount an antibody response after COVID infection. This is a retrospective study of adult lymphoma patients who received the COVID vaccine between 12/1/2020 and 11/30/2021. The primary endpoint was a...

Full description

Bibliographic Details
Main Authors: Alexandra Della Pia, Gee Youn (Geeny) Kim, Andrew Ip, Jaeil Ahn, Yanzhi Liu, Simone Kats, Michael Koropsak, Brittany Lukasik, Anamta Contractor, Krushna Amin, Lakshmi Ayyagari, Charles Zhao, Amolika Gupta, Mark Batistick, Lori A. Leslie, Andre H. Goy, Tatyana A. Feldman
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2022-01-01
Series:PLoS ONE
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9714943/?tool=EBI

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9714943/?tool=EBI

Similar Items